Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up

Ad

Connect Twitter with Market Wire News

Why Global Blood Therapeutics Stock Is Vaulting Higher Today


home / news releases / Why Global Blood Therapeutics Stock Is Vaulting Higher...

  • August, 05 2022 01:35 PM
  • |
  • Motley Fool
  • |
    • GBT
    • GBT Quote
    • GBT Short
    • GBT News
    • GBT Articles
    • GBT Message Board

Shares of rare-disease specialist Global Blood Therapeutics (NASDAQ: GBT) are rising sharply for the second day in a row. As of 12:38 p.m. ET, the drugmaker's stock was up by a healthy 38.4%.

Global Blood Therapeutics' shares have soared a whopping 104% so far this week. The biotech's stock has bolted higher in response to a report from Bloomberg News that multiple suitors are currently courting the drugmaker.

Image source: Getty Images.

Continue reading

For further details see:

Why Global Blood Therapeutics Stock Is Vaulting Higher Today

Get Email and Text Alerts for (NASDAQ:GBT)

Get Email and Text Alerts for (NASDAQ:GBT)

News, Short Squeeze, Breakout and More Instantly...

Tags
  • Asset Management
  • Healthcare
Share This Post

Market Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.


Contact the Author

Stock Information

Global Blood Therapeutics Inc. Company Name:

GBT Stock Symbol:

NASDAQ Market:

MENU
GBT GBT Quote GBT Short GBT News GBT Articles GBT Message Board
Get GBT Alerts

News, Short Squeeze, Breakout and More Instantly...

Ad

Connect Twitter with Market Wire News
RECENT GBT NEWS
  • GBT - Pfizer Inc (NYSE: PFE) To Acquire Global Blood Therapeutics For $5 Billion

    According to sources familiar with the matter, the Wall Street Journal reported that Pfizer Inc (NYSE: PFE) was in advanced discussions to acquire pharmaceutical company Global Blood Therapeutics (NASDAQ: GBT) for $5 billion. Pfizer, too, acquired Global Blood Therapeutics  Pfizer wants ...

  • GBT - Pfizer is acquiring Global Blood Therapeutics

    Pfizer Inc ( NYSE: PFE ) has executed a definitive merger agreement with Global Blood Therapeutics Inc ( NASDAQ: GBT ), whereby Pfizer will acquire the biopharmaceutical corporation dedicated to the delivery, development and discovery of life-changing medical treatment, ...

  • GBT - Why Global Blood Therapeutics Stock Was Trouncing the Market Today

    Trading in Global Blood Therapeutics (NASDAQ: GBT) stock was lively on Monday, with the blood-disorder-focused biotech rising by over 4% over Friday's close by midafternoon today. That's hardly surprising, as the company struck a deal to be acquired by one of the hottest operators i...

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Message Boards
  • Trending Stocks
  • Short Information
  • Stock Wall
  • Link Twitter
  • Coins
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Link your Twitter Account

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.



Sign up or login to continue

Sign up or login to continue.


Forgot password?




Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email support@marketwirenews.com.

WATCH LIVE TRENDING STOCKS

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected

Follow @marketwirenews

| Facebook

| Telegram

| LinkedIn

| Reddit

| Discord


Contact

Privacy

Terms of Service

Disclaimer

© 2022 Market Wire News